Acadia Healthcare Company, Inc. (ACHC) Rating Lowered to Neutral at Robert W. Baird

Robert W. Baird cut shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from an outperform rating to a neutral rating in a report released on Wednesday, October 25th, Marketbeat reports. They currently have $38.00 price objective on the stock, down from their prior price objective of $55.00.

A number of other analysts also recently weighed in on ACHC. Craig Hallum reaffirmed a buy rating and issued a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Zacks Investment Research downgraded shares of Acadia Healthcare from a buy rating to a hold rating in a research report on Tuesday, August 1st. UBS AG reaffirmed a positive rating and issued a $60.00 target price (up from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. BidaskClub downgraded shares of Acadia Healthcare from a hold rating to a sell rating in a research report on Friday, August 18th. Finally, Mizuho upped their target price on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a buy rating in a research report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company’s stock. Acadia Healthcare presently has a consensus rating of Hold and a consensus target price of $45.15.

Acadia Healthcare (NASDAQ:ACHC) opened at $28.23 on Wednesday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. The stock has a market cap of $2,480.12, a price-to-earnings ratio of 12.33, a price-to-earnings-growth ratio of 1.05 and a beta of 0.89. Acadia Healthcare has a 1 year low of $27.88 and a 1 year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.65 by ($0.07). The company had revenue of $716.70 million for the quarter, compared to analysts’ expectations of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The firm’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.58 earnings per share. equities research analysts predict that Acadia Healthcare will post 2.23 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Rating Lowered to Neutral at Robert W. Baird” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2017/11/12/acadia-healthcare-company-inc-achc-stock-rating-lowered-by-robert-w-baird.html.

In other Acadia Healthcare news, CEO Joey A. Jacobs sold 500,000 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $25,345,000.00. Following the transaction, the chief executive officer now owns 201,496 shares in the company, valued at approximately $10,213,832.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Ronald Morgan Fincher sold 80,000 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $4,055,200.00. Following the transaction, the chief operating officer now owns 59,071 shares in the company, valued at approximately $2,994,308.99. The disclosure for this sale can be found here. Insiders have sold a total of 1,824,040 shares of company stock worth $92,460,588 in the last 90 days. Company insiders own 11.10% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Teacher Retirement System of Texas lifted its stake in Acadia Healthcare by 0.4% during the 2nd quarter. Teacher Retirement System of Texas now owns 5,949 shares of the company’s stock valued at $294,000 after acquiring an additional 26 shares during the period. Public Employees Retirement Association of Colorado lifted its stake in shares of Acadia Healthcare by 0.9% in the 2nd quarter. Public Employees Retirement Association of Colorado now owns 17,798 shares of the company’s stock worth $879,000 after purchasing an additional 160 shares during the period. Pacer Advisors Inc. lifted its stake in shares of Acadia Healthcare by 2.2% in the 2nd quarter. Pacer Advisors Inc. now owns 10,365 shares of the company’s stock worth $512,000 after purchasing an additional 226 shares during the period. People s United Financial Inc. lifted its stake in shares of Acadia Healthcare by 3.4% in the 2nd quarter. People s United Financial Inc. now owns 7,459 shares of the company’s stock worth $368,000 after purchasing an additional 242 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Acadia Healthcare by 11.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after purchasing an additional 270 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply